Goldman Sachs’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Goldman Sachs’s Portfolio AMTI Stock Details AMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,889	Closed	-$3.8K	–	6175
2023 Q1	$3.8K	Buy	+11,889	New	+$6.21K	﹤0.01%	5817
2022 Q4	–	Sell	-23,192	Closed	-$23K	–	6365
2022 Q3	$23K	Sell	23,192 -22,837	-50%	-$40.3K	﹤0.01%	5913
2022 Q2	$134K	Sell	46,029 -27,166	-37%	-$114K	﹤0.01%	5771
2022 Q1	$550K	Sell	73,195 -57,249	-44%	-$474K	﹤0.01%	5256
2021 Q4	$1.82M	Buy	130,444 +53,912	+70%	+$1.06M	﹤0.01%	4326
2021 Q3	$1.98M	Buy	76,532 +46,635	+156%	+$1.48M	﹤0.01%	4208
2021 Q2	$1.37M	Buy	29,897 +11,764	+65%	+$556K	﹤0.01%	4529
2021 Q1	$798K	Buy	18,133 +4,787	+36%	+$233K	﹤0.01%	4777
2020 Q4	$411K	Sell	13,346 -6,270	-32%	-$199K	﹤0.01%	4725
2020 Q3	$624K	Sell	19,616 -39,123	-67%	-$960K	﹤0.01%	4361
2020 Q2	$1.48M	Buy	+58,739	New	+$1.48M	﹤0.01%	3674

Other funds holding AMTI

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

FFVM

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FFVM

Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Goldman Sachs's AMTI Position: Q2 2023 in Review

Goldman Sachs sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q2 2023, closing a stake of 11,889 shares — an estimated $3.8K sold.

Goldman Sachs first reported a position in AMTI in Q2 2020 and held it in 11 quarters. The position peaked at $1.98M in Q3 2021. 28 funds tracked by Wall St. Rank hold AMTI as of Q2 2023.

Goldman Sachs reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Goldman Sachs sold 11,889 Applied Molecular Transport Inc. Common Stock shares in Q2 2023, an estimated $3.8K.
Goldman Sachs first reported a position in Applied Molecular Transport Inc. Common Stock in Q2 2020 and held it in 11 quarters.
Goldman Sachs's Applied Molecular Transport Inc. Common Stock position peaked at $1.98M in Q3 2021.
28 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.